113 related articles for article (PubMed ID: 20628419)
1. Monitoring systemic complications of intraocular medications.
Pulido JS
Can J Ophthalmol; 2010 Jun; 45(3):215-7. PubMed ID: 20628419
[No Abstract] [Full Text] [Related]
2. Intravitreal bevacizumab (Avastin) treatment is safe in terms of intraocular and blood pressure.
Kernt M; Neubauer AS; Kampik A
Acta Ophthalmol Scand; 2007 Feb; 85(1):119-20. PubMed ID: 17244226
[No Abstract] [Full Text] [Related]
3. Identifying systemic safety signals following intravitreal bevacizumab: systematic review of the literature and the Canadian Adverse Drug Reaction Database.
Micieli JA; Micieli A; Smith AF
Can J Ophthalmol; 2010 Jun; 45(3):231-8. PubMed ID: 20628421
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.
Kumar V; Ghosh B; Raina UK; Goel N
Acta Ophthalmol; 2010 Mar; 88(2):e3; author reply e4. PubMed ID: 19549100
[No Abstract] [Full Text] [Related]
5. Bevacizumab local complications.
Gordon-Angelozzi M; Velez-Montoya R; Fromow-Guerra J; García-Aguirre G; Guerrero-Naranjo JL; Quiroz-Mercado H; Morales-Cantón V
Ophthalmology; 2009 Nov; 116(11):2264.e1-3. PubMed ID: 19883862
[No Abstract] [Full Text] [Related]
6. Herpetic epithelial keratitis after intravitreal injection of bevacizumab.
Sakarya Y; Sakarya R; Yildirim A
Cornea; 2010 Jul; 29(7):840; author reply 840. PubMed ID: 20574238
[No Abstract] [Full Text] [Related]
7. The effects of intravitreal ophthalmic medications on intraocular pressure.
Wu H; Chen TC
Semin Ophthalmol; 2009; 24(2):100-5. PubMed ID: 19373694
[TBL] [Abstract][Full Text] [Related]
8. Angiographic changes after bevacizumab.
Ikuno Y; Soga K; Wakabayashi T; Gomi F
Ophthalmology; 2009 Nov; 116(11):2263.e1. PubMed ID: 19883861
[No Abstract] [Full Text] [Related]
9. Systemic adverse events after bevacizumab.
Roth DB; King A; Weiss M; Klein D
Ophthalmology; 2009 Jun; 116(6):1226.e1. PubMed ID: 19486800
[No Abstract] [Full Text] [Related]
10. Tonic-clonic seizures following intravitreal bevacizumab injection.
Johnson D; Hollands H; Brox A; Sharma S
Can J Ophthalmol; 2010 Apr; 45(2):186-7. PubMed ID: 20379317
[No Abstract] [Full Text] [Related]
11. Bevacizumab: the need for controlled studies to move forward.
Buys YM
Can J Ophthalmol; 2007 Dec; 42(6):789. PubMed ID: 18059506
[No Abstract] [Full Text] [Related]
12. Re: Changes of intraocular pressure after intravitreal injection of bevacizumab (Avastin).
Utman SA; Dhillon B
Retina; 2008 Apr; 28(4):667; author reply 667-8. PubMed ID: 18398378
[No Abstract] [Full Text] [Related]
13. Controversies in the treatment of wet age-related macular degeneration.
Moreno SF; Paloma JB
Am J Ophthalmol; 2008 May; 145(5):937; author reply 938. PubMed ID: 18435977
[No Abstract] [Full Text] [Related]
14. Paracentesis before intravitreal injection of bevacizumab.
Tsui YP; Chiang CC; Tsai YY
Can J Ophthalmol; 2008 Apr; 43(2):239; author reply 239-40. PubMed ID: 18347632
[No Abstract] [Full Text] [Related]
15. Isolated sixth nerve palsy after intravitreal bevacizumab injection.
Cakmak HB; Toklu Y; Yorgun MA; Simşek S
Strabismus; 2010 Mar; 18(1):18-20. PubMed ID: 20230202
[TBL] [Abstract][Full Text] [Related]
16. Consecutive appearance of corneal subepithelial infiltrates after intravitreous bevacizumab injections.
Bourla DH; Dotan A; Weinberger D; Bourla N; Kremer I
Cornea; 2010 Jun; 29(6):686-7. PubMed ID: 20458242
[TBL] [Abstract][Full Text] [Related]
17. Metrorrhagia after intravitreal injection of bevacizumab.
Rodrigues EB; Shiroma H; Meyer CH; Maia M; Farah ME
Acta Ophthalmol Scand; 2007 Dec; 85(8):915-6. PubMed ID: 17645422
[No Abstract] [Full Text] [Related]
18. Off-label use of bevacizumab in retinopathy of prematurity.
Rishi E; Rishi P; Ratra D; Bhende M
Retina; 2009 Feb; 29(2):284; author reply 284-5. PubMed ID: 18854784
[No Abstract] [Full Text] [Related]
19. Early loss of pregnancy after intravitreal bevacizumab injection.
Petrou P; Georgalas I; Giavaras G; Anastasiou E; Ntana Z; Petrou C
Acta Ophthalmol; 2010 Jun; 88(4):e136. PubMed ID: 19740128
[No Abstract] [Full Text] [Related]
20. Rapid progression of angioid streaks following intravitreal bevacizumab.
Sen PR; Rishi P; Sen P; Rishi E; Shroff D
Can J Ophthalmol; 2009 Oct; 44(5):e39-40. PubMed ID: 19798813
[No Abstract] [Full Text] [Related]
[Next] [New Search]
